Pressroom
Natixis Provides 86 Million Construction Loan for Memorial Sloan Kettering Build-to-Suit Office Project
Natixis was the sole lead arranger for an $86.25 million floating-rate construction loan to affiliates of New York City-based Joy Construction and Maddd Equities. Loan proceeds will be used to pay off existing debt and to provide capital to complete a 110,727 square foot, Class A office building located at 330 East 62nd Street in New York City’s Upper East Side neighborhood.
The build-to-suit seven-story office is 100% pre-leased to Memorial Sloan Kettering Cancer Center for an initial term of 30 years. Memorial Sloan Kettering intends to use the building for administrative offices. The property sits in the center of Memorial Sloan Kettering’s Upper East Side presence and is within walking distance of its main hospital campus located at 1275 York Avenue.
Memorial Sloan Kettering Cancer Center is the world’s oldest and largest private cancer center with a total staff of 15,697 and operating revenues of $3.094 billion in 2016.
Joy Construction and Maddd Equities are repeat clients of Natixis. The financing was arranged by Kathy Anderson and Brad Domenico from Progress Capital in Tinton Falls, NJ.
Contacts
About Natixis
Natixis is a French multinational financial services firm specialized in asset & wealth management, corporate & investment banking, insurance and payments. A subsidiary of Groupe BPCE, the second-largest banking group in France through its two retail banking networks, Banque Populaire and Caisse d’Epargne, Natixis counts nearly 16,000 employees across 38 countries. Its clients include corporations, financial institutions, sovereign and supranational organizations, as well as the customers of Groupe BPCE’s networks. Listed on the Paris stock exchange, Natixis has a solid financial base with a CET1 capital under Basel 3(1) of €11.1 billion, a Basel 3 CET1 Ratio(1) of 11.5% and quality long-term ratings (Standard & Poor’s: A+ / Moody’s: A1 / Fitch Ratings: A+).
(1) Based on CRR-CRD4 rules as reported on June 26, 2013, including the Danish compromise - without phase-in. See note on methodology in the 2Q19 earnings material.
Figures as at 30 June 2019